PropertyValue
?:abstract
  • Coronavirus disease (COVID-19) can induce coagulopathy at the base of sepsis-induced coagulopathy (SIC), which is an important cause of death in these patients Cytokine storm causes imbalance in coagulation and fibrinolytic system A combination of hypercoagulability state, decrease or inhibition of fibrinolysis and endotheliopathy causes thromboembolic events Underlying diseases such as diabetes and hypertension with a high rate of mortality in COVID-19 and some conditions like aging and obesity are the main disorders with hemostatic disturbance and increase of coagulopathy Therefore, it seems that the combination of COVID-19 infection and these risk factors increase the risk of thromboembolic complications all together © 2020, Journal of Advances in Medical and Biomedical Research All rights reserved
is ?:annotates of
?:creator
?:journal
  • Journal_of_Advances_in_Medical_and_Biomedical_Research
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • A narrative review on evaluation of hypercoagulability state in severe covid-19 patients with background risk factors
?:type
?:who_covidence_id
  • #948308
?:year
  • 2020

Metadata

Anon_0  
expand all